illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Penumbra
Company logo

Penumbra | Sustainability Performance

https://www.penumbrainc.com/
Linkedin

Develops medical technologies used in interventional procedures for neurological and vascular conditions, producing devices intended to support clinical workflows and therapeutic interventions in specialized care settings.

2004

United States

1,001 - 5,000 employees

Medical Device

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9835
Overall
#2188
in United States
#142
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Nature and biodiversityNature riskClimate risk
Social
Diversity and inclusionPay gapsExternalities
Governance
TargetsSDG ImpactESG scores and exclusionsB-corp & CDP
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Envista

United States, Hospital & Health Care, Medical Device


Company logo
Encompass health

United States, Hospital & Health Care, Hospital & Health Care


Company logo
Cigna Healthcare

United States, Hospital & Health Care, Hospital & Health Care

Female engagement

43% 2024
Laggard

Externalities

854.8K $, 2024
Critical

Market cap

12.5B $, 2026▲19.1% YoY

Revenue

1.4B $, 2025▲14.9% YoY

R&D intensity

6.34% 2025

Female engagement

Reveal data for 1 credit

Share of female employees (%)

25
50
75
100
Company
Benchmark
Powered by illuminem and GIST Impact

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Penumbra Inc, US neurovascular/peripheral vascular medical devices, has faced multiple US FDA Form 483 observations including the historic 2020 USD 200+ million Jet 7 Reperfusion Catheter recall affecting US neurovascular customer sites, plus periodic class actions over alleged inadequate disclosure of US FDA enforcement affecting US institutional shareholders amid medical devices customer compliance.
Powered by illuminem

Climate risk

OverallAcuteChronic
Reveal data for 20 credits
Unlock Acute & Chronic
20 assets assessed
ScenarioComing soon
50Moderate
$7.6Mestimated revenue at risk
Thematic risk scoresESRS aligned scoresComing soon
Download Climate Risk AnalysisPowered by illuminem and GIST impact

Nature risk

Reveal data for 10 credits

Powered by GIST and illuminem

Production loss

Reveal data for 5 credits

Share of company output at risk (%)

Direct operations
Upstream supply chain
Powered by GIST and illuminem

Revenue at risk

Reveal data for 5 credits

Production-loss NVaR expressed in monetary terms ($)

Direct revenue at risk
Upstream revenue at risk
Powered by GIST and illuminem

Assets exposed to sensitive locations

Reveal data for 5 credits

Powered by GIST and illuminem

Biodiversity loss in km²

Reveal data for 2 credits

Biodiversity loss in terms of the equivalent land affected (km²e)

Total biodiversity loss (km²e)
Industry benchmark
Powered by GIST and illuminem

Biodiversity loss in CO2e

Reveal data for 2 credits

Total biodiversity loss as CO2e tonnes

Total biodiversity loss (CO2e tonnes)
Industry benchmark

Powered by GIST and illuminem

Potential species loss

Reveal data for 2 credits

Estimated nature species lost due to corporate activity, expressed as Potentially Disappeared Fraction (PDF)

One row per year, with the latest at the top. Each driver uses its own scale.

Low ImpactHigh Impact
Industry benchmark
Powered by GIST and illuminem

Biodiversity impact

Reveal data for 2 credits

KPIMetricYear
20202021202220232024Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
Powered by illuminem and GIST Impact
PDF: Potentially Disappeared Fraction (of species) due to corporate activities

Land use

Reveal data for 2 credits

KPIMetricYear
20202021202220232024Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
Powered by illuminem and GIST Impact

Diversity & inclusion

Reveal data for 3 credits

KPIMetricYear
20202021202220232024Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
Powered by illuminem and GIST Impact

Pay gap breakdown

Reveal data for 1 credit

KPIMetricYear
20202021202220232024Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
**************--****************************
********************************************************
Powered by illuminem and GIST Impact

Externalities

Reveal data for 1 credit

KPIMetricYear
20202021202220232024Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
Powered by illuminem and GIST Impact

Market cap

12.5B $, 2026▲19.1% YoY

Revenue

1.4B $, FY2025▲14.9% YoY

EBITDA

189.0M $, FY2025▼9.1% YoY

Operating margin

13% Industry: -136▲46.5% YoY

Revenue & EBITDA

$1.4BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Revenue by region


Revenue by region %

International
United States

Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

147.3M 2024▲44.3% YoY

Capex

21.0M 2024▲28.6% YoY

Debt/equity ratio

0.0 Industry: 1▼NaN% YoY

R&D intensity

6.3%FY2025

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

12.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

1.1

▼ 0.3%

2023

1.2

▲ 0.3%

2024

1.4

▲ 1.6%

2025

2.2

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

45%
Independent Directors

5 out of 11 incl. management

Powered by illuminem

Overall score

60

Environment

46

Social

72

Governance

63

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

CDP Scores


Climate Score

Not disclosed

Water Score

Not disclosed

A

A-

B

B-

C

C-

D

D-

Powered by illuminem and GIST impact

SDG impact

Reveal data for 5 credits
2024

Powered by illuminem and GIST Impact

SDG impact (historical)

Reveal data for 5 credits

KPIMetricYear
20192020202120222023Benchmark
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
********************************************************
Powered by illuminem and GIST Impact

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email